Exchange: NASDAQ·Updated 08:00 PM EDT
GNTA logo

GNTAGenenta Science SpA - ADR

$1.80
$0.04
(2.22%)
Today
Closed $1.84
$0.04
(2.17%)
Overnight
Mkt Cap$43.12M
Vol157,952.00
News
all
press releases
News Placeholder
Genenta Stock Rises Pre-Market After Cell Therapy Improves Survival In Certain Tumor Patients
The company said that 25 patients have been treated with Temferon as of November 21, and 44% of glioblastoma multiforme patients have reached 18-month survival.
Stocktwits
News Placeholder
GNTA Stock Skyrockets 300% Pre-Market Toward Record Highs: What’s Driving The Super Rally?
Stocktwits
<
...
1
>

Advertisement|Remove ads.